メマンチン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "メマンチン" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

6,690^th place

394^th place

3,258^th place

1,755^th place

274^th place

596^th place

low place

low place

222^nd place

498^th place

304^th place

20^th place

low place

low place

doi.org

Howard R, McShane R, Lindesay J, et al. (2012-03). “Donepezil and memantine for moderate-to-severe Alzheimer's disease”. N. Engl. J. Med. 366 (10): 893–903. doi:10.1056/NEJMoa1106668. PMID 22397651.
McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J (March 2019). “Memantine for dementia”. Cochrane Database Syst Rev 3: CD003154. doi:10.1002/14651858.CD003154.pub6. PMID 30891742.
Kurian R, Raza K, Shanthanna H (March 2019). “A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain”. Eur J Pain. doi:10.1002/ejp.1393. PMID 30848504.
Bisaga A, Comer SD, Ward AS, Popik P, Kleber HD, Fischman MW. (2001-8). “The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.”. Psychopharmacology (Berl). 157 (1): 1-10. doi:10.1007/s002130100739. PMID 11512037.
Thornton SL, Clark RF. (September 2014). “Encephalopathy from unintentional donepezil and memantine ingestion.”. Pediatric Emergency Care. 30 (9): 649-50. doi:10.1097/pec.0000000000000216.. PMID 25186510.
Seeman P, Caruso C, Lasaga M. (2008-2). “Memantine agonist action at dopamine D2High receptors.”. Synapse. 62 (2): 149-153. doi:10.1002/syn.20472. PMID 18000814.
加藤武「メマンチンによる治療 : MK-801との相違」『日本薬理学雑誌』第124巻第3号、日本薬理学会、2004年9月1日、145-151頁、doi:10.1254/fpj.124.145、NAID 10014284463。
Saab BJ, Luca RM, Yuen WB, Saab AM, Roder JC. (2011). “Memantine affects cognitive flexibility in the Morris water maze.”. J Alzheimers Dis. 27 (3): 477-482. doi:10.3233/jad-2011-110650. PMID 21860092.

iospress.com

content.iospress.com

Saab BJ, Luca RM, Yuen WB, Saab AM, Roder JC. (2011). “Memantine affects cognitive flexibility in the Morris water maze.”. J Alzheimers Dis. 27 (3): 477-482. doi:10.3233/jad-2011-110650. PMID 21860092.

nice.org.uk

TA217: Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (Report). 英国国立医療技術評価機構. March 2016.
英国国立医療技術評価機構 (November 2006). CG42 - Dementia: Supporting people with dementia and their carers in health and social care (Report). Chapt.1.6.2.3.

nih.gov

pubmed.ncbi.nlm.nih.gov

Howard R, McShane R, Lindesay J, et al. (2012-03). “Donepezil and memantine for moderate-to-severe Alzheimer's disease”. N. Engl. J. Med. 366 (10): 893–903. doi:10.1056/NEJMoa1106668. PMID 22397651.
McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J (March 2019). “Memantine for dementia”. Cochrane Database Syst Rev 3: CD003154. doi:10.1002/14651858.CD003154.pub6. PMID 30891742.
Hosenbocus S, Chahal R. (2013). “Memantine: a review of possible uses in child and adolescent psychiatry.”. Psychopharmacology (Berl). 22 (2): 166-171. PMC 3647634. PMID 23667364.
Kurian R, Raza K, Shanthanna H (March 2019). “A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain”. Eur J Pain. doi:10.1002/ejp.1393. PMID 30848504.
Bisaga A, Comer SD, Ward AS, Popik P, Kleber HD, Fischman MW. (2001-8). “The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.”. Psychopharmacology (Berl). 157 (1): 1-10. doi:10.1007/s002130100739. PMID 11512037.
Thornton SL, Clark RF. (September 2014). “Encephalopathy from unintentional donepezil and memantine ingestion.”. Pediatric Emergency Care. 30 (9): 649-50. doi:10.1097/pec.0000000000000216.. PMID 25186510.
Seeman P, Caruso C, Lasaga M. (2008-2). “Memantine agonist action at dopamine D2High receptors.”. Synapse. 62 (2): 149-153. doi:10.1002/syn.20472. PMID 18000814.
Saab BJ, Luca RM, Yuen WB, Saab AM, Roder JC. (2011). “Memantine affects cognitive flexibility in the Morris water maze.”. J Alzheimers Dis. 27 (3): 477-482. doi:10.3233/jad-2011-110650. PMID 21860092.

ncbi.nlm.nih.gov

Hosenbocus S, Chahal R. (2013). “Memantine: a review of possible uses in child and adolescent psychiatry.”. Psychopharmacology (Berl). 22 (2): 166-171. PMC 3647634. PMID 23667364.

nii.ac.jp

ci.nii.ac.jp

加藤武「メマンチンによる治療 : MK-801との相違」『日本薬理学雑誌』第124巻第3号、日本薬理学会、2004年9月1日、145-151頁、doi:10.1254/fpj.124.145、NAID 10014284463。

pmda.go.jp

info.pmda.go.jp

“メマリー医薬品インタビューフォーム（第10版）” (PDF). www.info.pmda.go.jp. 2016年5月3日閲覧。
“メマリー錠5mg／10mg／20mg／OD錠5mg／10mg／20mg 添付文書” (2016年3月). 2016年6月27日閲覧。

pmda.go.jp

“メマンチン塩酸塩国際共通化資料（CTD）『神経細胞保護作用』”. www.pmda.go.jp. 第一三共株式会社. 2016年5月14日閲覧。
“メマンチン塩酸塩国際共通化資料（CTD）非臨床試験の概括評価”. www.pmda.go.jp. 第一三共株式会社. 2016年7月29日閲覧。

springer.com

link.springer.com

Bisaga A, Comer SD, Ward AS, Popik P, Kleber HD, Fischman MW. (2001-8). “The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.”. Psychopharmacology (Berl). 157 (1): 1-10. doi:10.1007/s002130100739. PMID 11512037.

wiley.com

onlinelibrary.wiley.com

Seeman P, Caruso C, Lasaga M. (2008-2). “Memantine agonist action at dopamine D2High receptors.”. Synapse. 62 (2): 149-153. doi:10.1002/syn.20472. PMID 18000814.

wkhealth.com

meta.wkhealth.com

Thornton SL, Clark RF. (September 2014). “Encephalopathy from unintentional donepezil and memantine ingestion.”. Pediatric Emergency Care. 30 (9): 649-50. doi:10.1097/pec.0000000000000216.. PMID 25186510.